ID   LM-MEL-51
AC   CVCL_UH54
SY   LM-Mel-51; Ludwig Melbourne-MELanoma-51
DR   Wikidata; Q95982546
RX   PubMed=22970293;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Miscellaneous: Cell line information from personal communication of Cardwell T., Olivia Newton-John Cancer Research Institute.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 32.2
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
RX   PubMed=22970293; DOI=10.1371/journal.pone.0044707;
RA   Zhao R.Y., Mifsud N.A., Xiao K., Chan K.-F., Oveissi S., Jackson H.M.,
RA   Dimopoulos N., Guillaume P., Knights A.J., Lowen T., Robson N.C.,
RA   Russell S.E., Scotet E., Davis I.D., Maraskovsky E., Cebon J.S.,
RA   Luescher I.F., Chen W.-S.;
RT   "A novel HLA-B18 restricted CD8+ T cell epitope is efficiently
RT   cross-presented by dendritic cells from soluble tumor antigen.";
RL   PLoS ONE 7:E44707-E44707(2012).
//